Thyrocare Technologies Limited

THYROCAREFair value region

A 6-pillar fundamental profile. Each pillar scored 0–10.

6.6/10 composite
Prism for THYROCARE.NS: composite 6.6 of 10, verdict Fair value regionPULSEQUALITYMOATSAFETYGROWTHVALUE0.00.00.00.00.00.0

Pulse

9.0 · Positive

Analyst revision trend (fallback)

Pulse tracks recent momentum in price, analyst revisions, and news sentiment. Higher means stronger near-term tailwinds.

Quality

8.4 · Strong

Piotroski 8/9, ROCE 26.0%

Quality captures profitability, return on capital, and earnings consistency. Higher means a better business.

Moat

8.0 · Strong

Wide moat

Moat estimates durable competitive advantages — brand, scale, switching costs. Higher means more defensible.

Safety

8.9 · Strong

D/E 0.05, Int cov 48.7x

Safety looks at balance-sheet strength, leverage, and cash generation. Higher means lower financial risk.

Growth

3.0 · Weak

Rev CAGR 5.3%, EPS CAGR -31.7%

Growth reflects revenue and earnings expansion over recent years. Higher means faster compounding.

Value

4.2 · Weak

MoS 9%, P/E 44.7

Value measures whether the stock is cheap relative to its intrinsic worth. Higher is cheaper.

Compare with another stock

Overlay THYROCARE's prism against a peer.

Share this prism

Share on XWhatsApp

Get the full analysis

Interactive DCF, sensitivity, peer comparison, and AI summary for THYROCARE.

Full analysis →

Model estimate. Not investment advice. YieldIQ is not registered with SEBI as an investment adviser or research analyst. Past performance does not guarantee future results.